PharmaTher Holdings Ltd. is a specialty pharmaceutical company focused on developing and commercializing innovative delivery methods for pharmaceuticals. While the company has a strong liquidity position with a current ratio of 2.24 and no debt, it faces significant concerns with negative ROE and ROA, indicating operational inefficiencies. The low market cap of $5.01M and stagnant stock price suggest challenges in market perception and growth potential. Overall, while the company has a solid financial structure, its profitability metrics raise red flags for investors.
Loading financial metrics...
Company is burning $285K per quarter with $1.0M in cash. Approximately 3.6 quarters of runway at current burn rate.
Company posted a loss of $-1.6M over the last year, representing Infinity% of revenue.
Operating cash flow has been negative for 3 consecutive quarters, burning $1.1M over the last year.
Debt-free balance sheet with a solid cash position, providing significant financial flexibility.
Strong liquidity position with current ratio of 2.2x.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Biotechnology companies of a similar size
Based on 2025-Q3 (August 31, 2025)